New circular and biobased solutions require substantial capital investments for scale up. Financing is therefore a crucial factor. Depending on the market maturity of the specific solution and the profile of the parties involved, funding may be sourced from public sources, equity investors, loans by banks, or a combination thereof. ING is actively involved in mobilizing such funding, with the recent debt financing of the first of a kind bioplastics plant of Avantium as an example. Learnings from this case and other factors for a successful financing will be shared.